APO Research
Talk to an analyst

APO RESEARCH · REPORT

Toxoid

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Toxoid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025188 pages

Choose your research edition.

Industry ResearchToxoid Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Toxoid Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Toxoid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Toxoid Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Toxoid Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Toxoid market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Toxoid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Toxoid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Toxoid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Toxoid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Toxoid include Sanofi, Merck, GSK, Zoetis and Biocompare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Toxoid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Toxoid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Toxoid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Toxoid market size, projected growth trends, production technologies, key applications, and end-use industries.

Toxoid Segment by Company

Sanofi

Merck

GSK

Zoetis

Biocompare

Toxoid Segment by Type

Diphtheria Toxoid

Tetanic Toxoid

Others

Toxoid Segment by Application

Hospitals

Clinics

Others

Toxoid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Toxoid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Toxoid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Toxoid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Toxoid market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Toxoid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Toxoid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Toxoid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Toxoid Industry Trends Table 2. Toxoid Industry Drivers Table 3. Toxoid Industry Opportunities and Challenges Table 4. Toxoid Industry Restraints Table 5. Global Toxoid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Toxoid Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Toxoid Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Toxoid Sales Market Share by Manufacturers Table 9. Global Toxoid Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Toxoid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Toxoid Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Toxoid Manufacturers, Product Type & Application Table 13. Global Toxoid Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Toxoid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Diphtheria Toxoid Table 17. Major Manufacturers of Tetanic Toxoid Table 18. Major Manufacturers of Others Table 19. Global Toxoid Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Toxoid Sales by Type (2021-2026) & (K Units) Table 21. Global Toxoid Sales by Type (2027-2032) & (K Units) Table 22. Global Toxoid Sales Market Share by Type (2021-2026) Table 23. Global Toxoid Sales Market Share by Type (2027-2032) Table 24. Global Toxoid Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Toxoid Revenue by Type (2021-2026) & (K Units) Table 26. Global Toxoid Revenue by Type (2027-2032) & (K Units) Table 27. Global Toxoid Revenue Market Share by Type (2021-2026) Table 28. Global Toxoid Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Others Table 32. Global Toxoid Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Toxoid Sales by Application (2021-2026) & (K Units) Table 34. Global Toxoid Sales by Application (2027-2032) & (K Units) Table 35. Global Toxoid Sales Market Share by Application (2021-2026) Table 36. Global Toxoid Sales Market Share by Application (2027-2032) Table 37. Global Toxoid Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Toxoid Revenue by Application (2021-2026) & (K Units) Table 39. Global Toxoid Revenue by Application (2027-2032) & (K Units) Table 40. Global Toxoid Revenue Market Share by Application (2021-2026) Table 41. Global Toxoid Revenue Market Share by Application (2027-2032) Table 42. Global Toxoid Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Toxoid Sales by Region (2021-2026) & (K Units) Table 44. Global Toxoid Sales Market Share by Region (2021-2026) Table 45. Global Toxoid Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Toxoid Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Toxoid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Toxoid Sales by Country (2021-2026) & (K Units) Table 49. North America Toxoid Sales by Country (2027-2032) & (K Units) Table 50. Europe Toxoid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Toxoid Sales by Country (2021-2026) & (K Units) Table 52. Europe Toxoid Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Toxoid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Toxoid Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Toxoid Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Toxoid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Toxoid Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Toxoid Sales by Country (2027-2032) & (K Units) Table 59. Global Toxoid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Toxoid Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Toxoid Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Toxoid Revenue Market Share by Region (2021-2026) Table 63. Global Toxoid Revenue Market Share by Region (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Toxoid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sanofi Toxoid Product Portfolio Table 68. Sanofi Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Toxoid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck Toxoid Product Portfolio Table 73. Merck Recent Development Table 74. GSK Company Information Table 75. GSK Business Overview Table 76. GSK Toxoid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. GSK Toxoid Product Portfolio Table 78. GSK Recent Development Table 79. Zoetis Company Information Table 80. Zoetis Business Overview Table 81. Zoetis Toxoid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Zoetis Toxoid Product Portfolio Table 83. Zoetis Recent Development Table 84. Biocompare Company Information Table 85. Biocompare Business Overview Table 86. Biocompare Toxoid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Biocompare Toxoid Product Portfolio Table 88. Biocompare Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Toxoid Distributors List Table 92. Toxoid Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Toxoid Product Image Figure 2. Global Toxoid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Toxoid Market Size (2021-2032) & (US$ Million) Figure 4. Global Toxoid Sales (2021-2032) & (K Units) Figure 5. Global Toxoid Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Toxoid Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Diphtheria Toxoid Image Figure 9. Tetanic Toxoid Image Figure 10. Others Image Figure 11. Global Toxoid Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Toxoid Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Toxoid Sales Market Share by Type (2021-2032) Figure 14. Global Toxoid Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Toxoid Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Toxoid Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Toxoid Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Toxoid Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Toxoid Sales Market Share by Application (2021-2032) Figure 23. Global Toxoid Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Toxoid Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Toxoid Revenue Market Share by Application (2021-2032) Figure 26. North America Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Toxoid Sales Market Share by Country (2021-2032) Figure 28. U.S. Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Toxoid Sales Market Share by Country (2021-2032) Figure 33. Germany Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Toxoid Sales Market Share by Country (2021-2032) Figure 40. China Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Toxoid Sales Market Share by Country (2021-2032) Figure 48. Brazil Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Toxoid Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Toxoid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Toxoid Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Toxoid Revenue (2021-2032) & (US$ Million) Figure 59. North America Toxoid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Toxoid Revenue (2021-2032) & (US$ Million) Figure 61. Europe Toxoid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Toxoid Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Toxoid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Toxoid Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Toxoid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Toxoid Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Toxoid Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Diphtheria Toxoid
  • Tetanic Toxoid
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Sanofi
  • Merck
  • GSK
  • Zoetis
  • Biocompare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Toxoid Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Toxoid Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Toxoid Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Toxoid Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Toxoid Market Dynamics
  1. 2.1 Toxoid Industry Trends
  2. 2.2 Toxoid Industry Drivers
  3. 2.3 Toxoid Industry Opportunities and Challenges
  4. 2.4 Toxoid Industry Restraints
3 Toxoid Market by Manufacturers
  1. 3.1 Global Toxoid Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Toxoid Sales by Manufacturers (2021-2026)
  3. 3.3 Global Toxoid Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Toxoid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Toxoid Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Toxoid Manufacturers, Product Type & Application
  7. 3.7 Global Toxoid Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Toxoid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Toxoid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Toxoid Tier 1, Tier 2, and Tier 3
4 Toxoid Market by Type
  1. 4.1 Toxoid Type Introduction
  2. 4.1.1 Diphtheria Toxoid
  3. 4.1.2 Tetanic Toxoid
  4. 4.1.3 Others
  5. 4.2 Global Toxoid Sales by Type
  6. 4.2.1 Global Toxoid Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Toxoid Sales by Type (2021-2032)
  8. 4.2.3 Global Toxoid Sales Market Share by Type (2021-2032)
  9. 4.3 Global Toxoid Revenue by Type
  10. 4.3.1 Global Toxoid Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Toxoid Revenue by Type (2021-2032)
  12. 4.3.3 Global Toxoid Revenue Market Share by Type (2021-2032)
5 Toxoid Market by Application
  1. 5.1 Toxoid Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Toxoid Sales by Application
  6. 5.2.1 Global Toxoid Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Toxoid Sales by Application (2021-2032)
  8. 5.2.3 Global Toxoid Sales Market Share by Application (2021-2032)
  9. 5.3 Global Toxoid Revenue by Application
  10. 5.3.1 Global Toxoid Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Toxoid Revenue by Application (2021-2032)
  12. 5.3.3 Global Toxoid Revenue Market Share by Application (2021-2032)
6 Global Toxoid Sales by Region
  1. 6.1 Global Toxoid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Toxoid Sales by Region (2021-2032)
  3. 6.2.1 Global Toxoid Sales by Region (2021-2026)
  4. 6.2.2 Global Toxoid Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Toxoid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Toxoid Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Toxoid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Toxoid Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Toxoid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Toxoid Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Toxoid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Toxoid Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Toxoid Revenue by Region
  1. 7.1 Global Toxoid Revenue by Region
  2. 7.1.1 Global Toxoid Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Toxoid Revenue by Region (2021-2026)
  4. 7.1.3 Global Toxoid Revenue by Region (2027-2032)
  5. 7.1.4 Global Toxoid Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Toxoid Revenue (2021-2032)
  8. 7.2.2 North America Toxoid Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Toxoid Revenue (2021-2032)
  11. 7.3.2 Europe Toxoid Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Toxoid Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Toxoid Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Toxoid Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Toxoid Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Toxoid Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Toxoid Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Toxoid Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Toxoid Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Toxoid Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Toxoid Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Zoetis
  20. 8.4.1 Zoetis Company Information
  21. 8.4.2 Zoetis Business Overview
  22. 8.4.3 Zoetis Toxoid Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zoetis Toxoid Product Portfolio
  24. 8.4.5 Zoetis Recent Developments
  25. 8.5 Biocompare
  26. 8.5.1 Biocompare Company Information
  27. 8.5.2 Biocompare Business Overview
  28. 8.5.3 Biocompare Toxoid Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Biocompare Toxoid Product Portfolio
  30. 8.5.5 Biocompare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Toxoid Value Chain Analysis
  2. 9.1.1 Toxoid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Toxoid Production Mode & Process
  6. 9.2 Toxoid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Toxoid Distributors
  9. 9.2.3 Toxoid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst